TVRD

Tvardi Therapeutics, Inc. Common Stock

121 hedge funds and large institutions have $222M invested in Tvardi Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-6
Holders Change %
-4.72%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
30
Reduced
35
Closed
20
Calls
$3.9M
Puts
$7.22M
Net Calls
-$3.33M
Net Calls Change
-$1.44M
Name Holding Trade Value Shares
Change
Shares
Change %
RJA
126
Raymond James & Associates
Florida
-$199K -453 Closed
Two Sigma Advisers
127
Two Sigma Advisers
New York
-$198K -450 Closed
ARTA
128
A.R.T. Advisors
New York
-$197K -447 Closed
PP
129
Paloma Partners
Connecticut
-$167K -378 Closed
FRM
130
Fox Run Management
Connecticut
-$157K -356 Closed
Simplex Trading
131
Simplex Trading
Illinois
-$154K -352 Closed
CAN
132
Cetera Advisor Networks
California
-$125K -293 Closed
D.E. Shaw & Co
133
D.E. Shaw & Co
New York
-$127K -287 Closed
MA
134
MANA Advisors
New York
-$125K -283 Closed
Russell Investments Group
135
Russell Investments Group
United Kingdom
-$80K -173 Closed
Pacer Advisors
136
Pacer Advisors
Pennsylvania
-$54K -122 Closed
Parallax Volatility Advisers
137
Parallax Volatility Advisers
California
-$50K -113 Closed
BBHC
138
Brown Brothers Harriman & Co
New York
-$38K -86 Closed